Article Text

Download PDFPDF
Lessons for injury epidemiology and control learned from the COVID-19 pandemic
  1. Louis-Rachid Salmi
  1. ISPED/Inserm U-1219/Injury Epidemiology Transportation Occupation Team, Université de Bordeaux Collège Sciences de la Santé, Bordeaux, France
  1. Correspondence to Professor Louis-Rachid Salmi, ISPED/Inserm U-1219/Injury Epidemiology Transportation Occupation Team, Université de Bordeaux Collège Sciences de la Santé, Bordeaux 33076, Aquitaine, France; louis-rachid.salmi{at}u-bordeaux.fr

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In October 2021, the Organisation for Economic Co-operation and Development organised a virtual event on ‘Priority setting and coordination of research agendas: lessons learnt from the COVID-19 pandemic’.1 Over 4 days, the event addressed key issues around data collection, development of an evidence base, coordination and preparedness for crises. Other international or national public health agencies (eg, see reference 2 for France) have taken similar initiatives. Many of the issues raised during the workshops question the ability of national and international public health systems to tackle acute catastrophic events such as pandemics. Although the focus was clearly transmissible diseases, issues are also relevant to the impact of such catastrophes on the ability of a society to continue dealing with other health problems. For the readership of Injury Prevention, these include the endemic occurrence of injuries, but also the impact of a crisis and subsequent policies and interventions on mental health, …

View Full Text

Footnotes

  • Contributors RS conceived, wrote and edited the article.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

  • Provenance and peer review Commissioned; internally peer reviewed.